PRIMECAP Management acquired 2.3 Million Edwards Lifesciences shares worth $169 Million. That's 0.14% of their equity portfolio (105th largest holding). The first Edwards Lifesciences trade was made in Q1 2013. Since then PRIMECAP Management bought shares six more times and sold shares on eleven occasions. The stake costed the investor $100 Million, netting the investor a gain of 69% so far.
New York Life Investment Management LLC reduced its position in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 1.9% in the 2nd quarter, Holdin...
Northwest Capital Management Inc acquired a new position in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) during the 2nd quarter, according to i...
Baldwin Investment Management LLC cut its stake in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 15.8% in the 2nd quarter, according to its m...
EFG Asset Management North America Corp. reduced its stake in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 35.9% during the 2nd quarter, acc...